Konstantinos Toutouzas Selected Research

Acute Coronary Syndrome

1/2018	Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry.
8/2017	Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE-CARDIOGROUP IV and USZ registry.
4/2016	SCAI expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Intervencionista).
8/2015	Impact of coronary artery stent edge dissections on long-term clinical outcome in patients with acute coronary syndrome: an optical coherence tomography study.
1/2013	MicroRNAs in the diagnosis and treatment of unstable angina.
6/2010	Percutaneous coronary intervention in chronic stable angina.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Konstantinos Toutouzas Research Topics

Disease

19	Myocardial Infarction 03/2024 - 08/2002
18	Thrombosis (Thrombus) 03/2024 - 01/2002
16	Inflammation (Inflammations) 07/2023 - 10/2004
14	Aortic Valve Stenosis (Aortic Stenosis) 02/2024 - 11/2010
13	Neoplasms (Cancer) 12/2023 - 02/2012
13	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 10/2008
11	Hypertension (High Blood Pressure) 08/2023 - 03/2003
11	Stroke (Strokes) 05/2023 - 04/2016
11	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 06/2007
10	Hemorrhage 05/2023 - 03/2003
9	ST Elevation Myocardial Infarction 01/2024 - 06/2011
8	Atrial Fibrillation 05/2024 - 10/2013
8	Atherosclerosis 01/2024 - 06/2010
7	Pathologic Constriction (Stenosis) 03/2024 - 07/2005
7	Atherosclerotic Plaque (Atheroma) 01/2018 - 03/2003
6	Hypersensitivity (Allergy) 04/2024 - 01/2021
6	COVID-19 12/2023 - 10/2020
6	Cardiotoxicity 05/2023 - 03/2016
6	Stable Angina 01/2021 - 07/2007
6	Rupture 01/2021 - 05/2010
6	Acute Coronary Syndrome 01/2018 - 06/2010
5	Infections 12/2023 - 05/2007
5	Diabetes Mellitus 01/2022 - 03/2008
5	Hyperplasia 12/2014 - 01/2002
4	Heart Failure 08/2023 - 11/2010
4	Sepsis (Septicemia) 05/2023 - 04/2011
4	Wounds and Injuries (Trauma) 03/2020 - 05/2007
4	Ischemia 05/2016 - 06/2014
3	Heart Diseases (Heart Disease) 08/2023 - 01/2016
3	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2017
3	Fibrosis (Cirrhosis) 02/2021 - 07/2019
3	Coronary Disease (Coronary Heart Disease) 09/2019 - 01/2015
3	Reperfusion Injury 05/2016 - 06/2014
2	Patent Foramen Ovale 10/2023 - 06/2022
2	Heart Arrest (Cardiac Arrest) 02/2023 - 01/2022
2	Cardiac Arrhythmias (Arrythmia) 01/2023 - 10/2013
2	Atrial Heart Septal Defects (Atrial Septal Defect) 06/2022 - 01/2020
2	Hyperlipidemias (Hyperlipidemia) 10/2021 - 09/2013
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2013
2	Unstable Angina 10/2020 - 01/2013
2	Embolic Stroke 01/2019 - 12/2009
2	Cardiomyopathies (Cardiomyopathy) 01/2018 - 11/2010
2	Non-ST Elevated Myocardial Infarction 10/2016 - 06/2011
2	Hypoxia (Hypoxemia) 07/2015 - 01/2015
2	Hyperemia 11/2010 - 04/2007
2	Aneurysm (Aneurysms) 01/2006 - 02/2002
1	Ischemic Stroke 05/2024

Drug/Important Bio-Agent (IBA)

11	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 11/2004
10	LipidsIBA 12/2023 - 05/2010
9	omega-Chloroacetophenone (Mace)IBA 03/2024 - 10/2008
9	Biomarkers (Surrogate Marker)IBA 05/2023 - 12/2009
6	NickelIBA 04/2024 - 01/2021
6	U 74389FIBA 01/2018 - 01/2015
6	Bevacizumab (Avastin)FDA Link 05/2017 - 01/2006
5	C-Reactive ProteinIBA 01/2021 - 06/2007
5	AntioxidantsIBA 01/2018 - 12/2011
4	TroponinIBA 01/2024 - 01/2019
4	ElementsIBA 05/2023 - 01/2010
4	CalciumIBA 06/2021 - 12/2011
4	Everolimus FDA Link 01/2021 - 01/2015
4	Clopidogrel (Plavix)FDA Link 01/2021 - 01/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 02/2009
4	Adenosine (Adenocard)FDA LinkGeneric 07/2019 - 04/2007
3	AnticoagulantsIBA 05/2024 - 01/2019
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 02/2023 - 07/2022
3	TicagrelorIBA 01/2021 - 01/2015
3	AnthracyclinesIBA 10/2020 - 01/2018
3	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2013
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2005 - 01/2002
2	Proteins (Proteins, Gene)FDA Link 08/2023 - 06/2010
2	Natriuretic PeptidesIBA 05/2023 - 01/2019
2	VaccinesIBA 01/2022 - 07/2020
2	Antihypertensive Agents (Antihypertensives)IBA 12/2020 - 01/2019
2	Monoclonal AntibodiesIBA 11/2019 - 01/2018
2	Malondialdehyde (Propanedial)IBA 01/2018 - 09/2015
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 03/2016
2	Diphosphonates (Bisphosphonates)IBA 01/2016 - 09/2014
2	Dobutamine FDA LinkGeneric 10/2015 - 05/2014
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2014 - 12/2011
2	MetalsIBA 07/2013 - 01/2011
2	Phenobarbital (Luminal)FDA Link 06/2011 - 10/2008

Therapy/Procedure

27	Stents 03/2024 - 01/2002
21	Therapeutics 12/2023 - 07/2010
17	Percutaneous Coronary Intervention 02/2023 - 10/2004
14	Transcatheter Aortic Valve Replacement 02/2024 - 11/2010
12	Drug-Eluting Stents 02/2023 - 11/2007
6	Drug Therapy (Chemotherapy) 01/2021 - 07/2010
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 08/2002
4	Radiotherapy 05/2023 - 01/2013
3	Cardiopulmonary Resuscitation (CPR) 02/2023 - 10/2016
3	Prostheses and Implants (Prosthesis) 01/2021 - 01/2019
3	Carotid Endarterectomy 08/2019 - 05/2012
3	Secondary Prevention 10/2017 - 07/2010
3	Length of Stay 02/2014 - 05/2007
2	Liver Transplantation 12/2020 - 12/2020
2	Electric Countershock (Cardioversion) 10/2017 - 12/2009
2	Denervation 10/2017 - 07/2013
2	Transplantation 01/2016 - 04/2011
2	Catheters 09/2014 - 03/2003
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 03/2024